Does Giving Intravenous (IV) Iron After Surgery Help Head and Neck Cancer Patients Start Their Next Stage of Treatment on Time?

Intravenous iron in RIOT among anaemic postoperative Head and Neck cancer patients at a tertiary care institution in Kerala - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109628

Enrollment

Registered

2026-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Intravenous iron: single dose of 1000 mg IV Ferric Carboxymaltose given on 1st postoperative day Control Intervention1: oral ferrous fumarate: oral ferrous fumarate 200mg will be given

Eligibility

Inclusion criteria

Inclusion criteria: Postop patients with hemoglobin less than 10gm,dL on first postoperative day

Exclusion criteria

Exclusion criteria: known hypersensitivity to iron preparations

Design outcomes

Primary

Measure	Time frame
Hemoglobin levelTimepoint: 4 weeks after surgery	—

Secondary

Measure	Time frame
ICU & total hospital stay, total units of packed red blood cells transfused within the first five postoperative days, free flap failureTimepoint: ICU & total hospital stay will be noted at time of discharge from hospital after surgery. Total units of packed red blood cells transfused within the first five postoperative days will be noted on 6th postoperative day. Any incidence of free flap failure will be noted at time of discharge from hospital after surgery.	—

Measure

Time frame

ICU & total hospital stay, total units of packed red blood cells transfused within the first five postoperative days, free flap failureTimepoint: ICU & total hospital stay will be noted at time of discharge from hospital after surgery. Total units of packed red blood cells transfused within the first five postoperative days will be noted on 6th postoperative day. Any incidence of free flap failure will be noted at time of discharge from hospital after surgery.

—

Countries

India

Contacts

Public ContactDr Sunil Rajan

Amrita Institute of Medical Sciences, Kochi

sunilrajan@aims.amrita.edu9447464652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026